Adial Pharmaceuticals
ADIL
19 hedge funds and large institutions have $1.95M invested in Adial Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
48% more capital invested
Capital invested by funds: $1.31M → $1.95M (+$637K)
36% more funds holding
Funds holding: 14 → 19 (+5)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$89.2K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.8K |
| 3 |
Barclays
London,
United Kingdom
|
+$37.8K |
| 4 |
RW
Rede Wealth
Charlottesville,
Virginia
|
+$36.3K |
| 5 |
OC
Oppenheimer & Co
New York
|
+$34.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$168K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$16.6K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$6.04K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.51K |
ADIL Hedge Fund Activity: Q1 2021 in Review
19 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q1 2021, worth a combined $1.95M — up 48% from $1.31M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ADIL positions and 1 closed out — a net gain of 5 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Private Advisor Group, opening a new position worth an estimated $89.2K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $168K sold.
- 19 institutional investors held Adial Pharmaceuticals (ADIL) as of Q1 2021, up from 14 in Q4 2020.
- Funds reported $1.95M of Adial Pharmaceuticals stock for Q1 2021, up 48% quarter-over-quarter.
- 6 funds opened new Adial Pharmaceuticals positions in Q1 2021 and 1 closed out, a net change of +5 holders.
- The largest Adial Pharmaceuticals buyer in Q1 2021 was Private Advisor Group, an estimated $89.2K added.
- The largest Adial Pharmaceuticals seller in Q1 2021 was Renaissance Technologies, an estimated $168K sold.
Based on aggregated 13F filings for Q1 2021.